Logo

Kirk Wojno

Jul 18, 2019

OncoCell MDx, an immunogenomics company developing noninvasive molecular diagnostic assays, has named Kirk Wojno as chief medical officer. Wojno is former head of urologic pathology at the University of Michigan; at Ascension Health System; and AmeriPath, a division of Quest Diagnostics. He has more than 30 years in medical practice and most recently served as the chief of pathology and laboratory services and director of cinical research for the Comprehensive Urology practice in Royal Oak, Michigan.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.